{
  "docId": "019de072-1de2-7119-a555-9ff409e7e548",
  "docSlug": "506aa41f1d83c0fffcc1a747d59c4e2b",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 86 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 46,
  "pageCount": 86,
  "prevPage": 45,
  "nextPage": 47,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 60,
  "notes": "Includes a specific callout for a 16% revenue increase in specific products.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-1de2-7119-a555-9ff409e7e548/46",
  "deckHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548",
  "deckJsonHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548.json",
  "deckAnchorHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548#slide-46",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.23,
        "x": 0.75,
        "y": 0.17
      },
      "kind": "callout",
      "text": "+16% WELLBUTRIN/APLENZIN combined reported revenue increase vs. 4Q20, driven by net realized pricing on WELLBUTRIN/APLENZIN and higher APLENZIN volume",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7517cd6e-b6a6-4cd1-9e19-1c20bfe5d76d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.33,
        "x": 0.65,
        "y": 0.02
      },
      "kind": "callout",
      "text": "New disclosure that includes additional GAAP measures",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b5816fd9-e0e6-40d0-8b13-40549cba9007",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.73,
        "x": 0.25,
        "y": 0.9
      },
      "kind": "disclaimer",
      "text": "1. This is a non-GAAP measure... 2. See Non-GAAP Appendix... 3. Organic growth/change... 4. U.S. sales only. 5. See footnote 3 at slide 9...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22f7c4dd-64f2-4c3e-a945-81ed6428bd70",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.65,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "table",
      "text": "Financial performance table showing revenue, gross profit, margins, operating expenses, and segment profit for 4Q21 vs 4Q20.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cee2c6a8-709b-4c4b-a7d1-c0b8bac72bd7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.2,
        "y": 0.07
      },
      "kind": "title",
      "text": "4Q 21 Financial Results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8e87c55-2d8b-4b05-bcf4-7592de2eb2ef",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}